CCL2 and diabetic kidney disease: In mice, blocking macrophage infiltration via inhibition of CCR2 (the receptor for CCL2/monocyte chemotactic protein-1) reduces renal fibrosis and inflammation and improves renal function in diabetic kidney disease, suggesting that infiltrating macrophages might play a causative role in the progression of renal fibrosis [56].